DISCLAIMER/DISCLOSURE
The disclaimer is to be read and fully understood before using our site or subscribing to our newsletter.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE, VIDEOS OR NEWSLETTER. THE ARTICLES AND/OR VIDEOS PROVIDED AND ANY COMMENTARY ARE FOR ENTERTAINMENT PURPOSES ONLY. ALWAYS CONSULT A QUALIFIED INVESTMENT ADVISOR BEFORE MAKING ANY INVESTMENT DECISIONS. INVESTING INVOLVES A HIGH DEGREE OF RISK IN WHICH YOU COULD LOSE UP TO 100% OF YOUR INVESTMENT!
Neither www.emergingbiotechs.com nor its officers, directors, partners, employees or anyone involved in the publication of this website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. Past performance of companies profiled on our website is not indicative of future results. Nothing on this website is an endorsement or solicitation to buy or sell any security in any way, shape or form. We are not qualified in any sense to provide recommendations or advice. Some companies profiled within this website and/or newsletters may lack a liquid trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Never invest in any security featured on our website or newsletters unless you can afford to lose your entire investment.
All material posted on our website is for informational and entertainment purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. By reading this website, you are accepting sole responsibility for your own investment decisions and you acknowledge that the information contained herein is provided solely for general discussion and informational purposes and, therefore, should not be considered to be complete, precise, accurate, or current investment advice. The decision to buy or sell any security that may be featured on our websites or newsletters is done solely at the subscriber’s own risk.
Our website and company profiles have been prepared for informational and entertainment purposes only and are not intended to be used as a complete source of information. You should never buy or sell any securities based solely on information contained in our website or in any company profiles or videos. Further, you should assume that all information provided regarding in our website is not reliable unless verified by your own independent research.
Through use of our website, you agree to hold us harmless and to completely release us from any and all liability due to any and all loss, damage, or injury, monetary or otherwise, that you may incur.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided on this website or in any company profile, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
Investing in securities is speculative and carries serious risk. No investment should be made unless you can afford to lose your entire investment. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies mentioned. ALWAYS consult an investment adviser or broker-dealer before purchasing or selling any securities viewed on or mentioned on this website or our newsletters. Invest at your own risk.
Information contained on our website or in the company profiles will contain “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” or statements indicating certain actions “may,” “could,” or “might” occur.
It is possible that some of the companies listed within our videos, articles, newsletters, alerts or on a section of our website may have compensated us to be profiled. These companies (or affiliates) have retained us to perform public relations, or media relations or even investor relation services including promotional services that consist of the placement of the profiled companies on our website or newsletters to our subscribers. If compensation has been received, we will comply with the full disclosure requirements as outlined in RULE 17(b) Section 17(b) of the 1933 Act, which provides that it is unlawful for any person: “to publish, give publicity to, or to circulate any notice, circular, or advertisement, newspaper article, letter, investment service, or communication which, though not purporting to offer a security for sale, describes such security for a consideration received or to be received, directly or indirectly, from an issuer, underwriter or dealer, without fully disclosing receipt, whether past or prospective, of such compensation and the amount thereof.” The specific compensation type and amounts that we have been paid from each respective client company will be provided in detail within each email newsletter and/or disclosure portion of our website. While we typically will not accept free trading shares for compensation, it is possible that others are selling shares into the market. In any case, compensation received, in the form of shares or cash, can be construed as a conflict of interest in formation of our opinions and must be duly noted by the readers of this website.
From time to time we will provide subscribers with links to third party websites or content and are in no way responsible for any of the content or information provided within such links. Under no circumstances will we be held liable for any losses incurred by the use of information contained within our email newsletters or information provided to subscribers of our website.
Information contained in a company profile was extracted from current documents filed with the SEC, the company’s websites and other publicly available sources. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment. Past performance is not an indicator of future returns.
The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.
IF YOU DO NOT AGREE WITH THE TERMS SET FORTH IN THIS DISCLAIMER, YOU SHOULD EXIT OUR WEBSITE IMMEDIATELY. YOUR USE OF OUR WEBSITE AND THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THIS DISCLAIMER.
————————————————————————————————
Please Note Well: Neither EmergingBiotechs.com nor its employees are registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever.
Investing in securities is speculative and carries risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies mentioned in posts, articles, charts, newsletters and videos.
AGAIN: It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies mentioned. Invest at your own risk.
EmergingBiotechs.com makes no recommendation that the securities of the companies mentioned or profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through EmergingBiotechs.com. Investing in securities is highly speculative and carries an extremely high degree of risk. Everything stated in and on EmergingBiotechs.com and its alerts are based on opinion and are to be used for entertainment purposes only. ALWAYS consult a broker before purchasing or selling any securities viewed on or mentioned herein.
By subscribing to EmergingBiotechs.com or its newsletter, you acknowledge and agree to the disclaimer hereunto pertaining:
EmergingBiotechs.com nor its officers, directors, partners, employees, nor anyone involved in the publication of this website or its email newsletters is a registered investment adviser or broker/dealer and none of the foregoing make any recommendation that the purchase of securities of any company profiled in this website or its email newsletters is suitable or advisable for any person or that an investment in such securities will be profitable. Past performance of profiled securities is not indicative of future results. Some companies profiled within this website and/or EmergingBiotechs.com email alerts may lack a liquid trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Anyone investing in these companies should be able and prepared to lose their entire investment.
The information provided on this website or in the newsletter is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. Everything stated in EmergingBiotechs.com and its videos and newsletter are based on opinion and are to be used for entertainment purposes only.
EmergingBiotechs.com is wholly-owned by Viper Enterprises, LLC. In most cases, EmergingBiotechss.com scans, picks, produces and provides articles and video charts for the partner websites as simply content. In some cases, requests are made for specific articles or charts for which we have no idea if the request is part of an investor awareness/advertising campaign. If such is the case to the best of our knowledge and we are compensated, the disclosure will be presented here to remain SEC compliant. Additionally, any compensation received through the parent company of Viper Enterprises, LLC will also be disclosed here.
January 30, 2011 – Viper Enterprises (parent company of SMVC) has received receive 50,000 restricted shares as compensation for providing company information, market awareness, consultation and literary services from BioMedical Technology Solutions (contract ended on March 24, 2011). No shares have been sold at this time.
January 30, 2011 – StockMarketVideoCharts.com has been compensated $350 by Price Target Media, Inc. for a BILB video stock chart.
January 30, 2011 – Viper Enterprises (parent company of SMVC) has received 750,000 restricted shares as compensation for providing consultation services from Prime Star Group, Inc. (180 days of services). No shares have been sold at this time.
January 31, 2011 – StockMarketVideoCharts.com has been compensated $350 by a Cream Consulting LLC for an EXPU video stock chart.
February 8, 2011 – Viper Enterprises (parent company of SMVC) has received receive 50,000 restricted shares as compensation for providing company information, market awareness, consultation and literary services from Cellceutix Corporation (contract ends on August 8, 2011). No shares have been sold at this time.
February 25, 2011 – StockMarketVideoCharts.com has been compensated $350 by IRPRO2.0, Inc. for a XWND video stock chart.
March 4, 2011 – StockMarketVideoCharts.com has been compensated $350 by IRPRO2.0, Inc. for a SHOM video stock chart.
March 9, 2011 – StockMarketVideoCharts.com has been compensated $350 by Position Media Group for a GEFI video stock chart.
March 15, 2011 – StockMarketVideoCharts.com has been compensated $350 by Cream Consulting LLC for a EVPH video stock chart.
March 17, 2011 – StockMarketVideoCharts.com has been compensated $350 by Cream Consulting LLC for a GEFI video stock chart.
March 22, 2011 – StockMarketVideoCharts.com has been compensated $350 by Price Target Media, Inc. for a THWI video stock chart.
March 26, 2011 – StockMarketVideoCharts.com has been compensated $350 by Evergreen Marketing, Inc. for a RENS video stock chart.
March 26, 2011 – StockMarketVideoCharts.com has been compensated $350 by IRPRO2.0, Inc. for a CMGO video stock chart.
March 27, 2011 – StockMarketVideoCharts.com has been compensated $350 by IRPRO2.0, Inc. for a SHOM video stock chart.
April 29, 2011 – StockMarketVideoCharts.com has been compensated $350 by IRPRO2.0, Inc. for a XWND video stock chart.
April 29, 2011 – StockMarketVideoCharts.com has been compensated $350 by IRPRO2.0, Inc. for a SHOM video stock chart.
May 8, 2011 – StockMarketVideoCharts.com has been compensated $300 by Evergreen Marketing, Inc. for a CTIX video stock chart.
May 23, 2011 – StockMarketVideoCharts.com has been compensated $300 by IRPRO2.0, Inc. for a SHOM video stock chart.
June 8, 2011 – StockMarketVideoCharts.com has been compensated $300 by IRPRO2.0 for a MMOG video stock chart.
June 8, 2011 – StockMarketVideoCharts.com has been compensated $300 by IRPRO2.0 for a SHOM video stock chart.
